Mayo Clinic

Two-drug combination may slow deadly thyroid cancer

A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine. The two drugs togeth ...

Jan 08, 2013
popularity 5 / 5 (1) | comments 0 | with audio podcast

Researchers identify enzyme linked to prostate cancer

Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic ...

Dec 18, 2012
popularity not rated yet | comments 0 | with audio podcast

Study unmasks regulator of healthy life span

A new series of studies in mouse models by Mayo Clinic researchers uncovered that the aging process is characterized by high rates of whole-chromosome losses and gains in various organs, including heart, muscle, kidney and ...

Dec 17, 2012
popularity 5 / 5 (2) | comments 0 | with audio podcast